The era of biologic therapy has transformed the management of rheumatoid arthritis. Biologics and other novel drugs that block inflammatory pathways have been shown to halt joint damage in addition to improving rheumatoid arthritis symptoms of pain, swelling, and joint stiffness. A “treat to target” strategy for remission has become achievable in early management of rheumatoid arthritis, but health care providers must be knowledgeable about the nuances of available treatments to reach desired therapeutic goals. Clinical Care Options provides a range of rheumatoid arthritis CME options designed for physicians, nurses and other health care providers. Rheumatoid arthritis CE that is current and relevant will help providers stay abreast of the latest advances in patient care that addresses the various elements of this complex disease.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.